SCHEMBL2726604

SCHEMBL2726604

N[C@H](c1ccccc1)c1ccccc1-c1c(C(=O)O)n(S(=O)(=O)c2ccccc2)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.41
HTR6 P50406 6/20 0.38
AGTR1 P30556 3/20 0.38
FABP3 P05413 2/20 0.36
FABP4 P15090 2/20 0.36
FABP5 Q01469 2/20 0.36
SRC P12931 1/20 0.35
RECQL P46063 1/20 0.35
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CXCL8 P10145 1/20 0.34
NOD1 Q9Y239 1/20 0.34
FABP2 P12104 1/20 0.34
AKR1C3 P42330 1/20 0.33
AKR1C1 Q04828 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2732153 0.85 ACLY (0.40) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL2724860 0.84 ACLY (0.39) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL2733172 0.81 ACLY (0.37) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL28019783 0.70 AGTR1 (0.47) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL6829775 0.70 AKR1C3 (0.48) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL4119321 0.70 ACLY (0.51) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL2732076 0.70 FABP3 (0.50) ACLYHTR6AGTR1FABP3FABP4
SCHEMBL2732065 0.70 HTR6 (0.42) ACLYHTR6PSEN1PSEN2APH1B
SCHEMBL2733056 0.70 HTR6 (0.42) ACLYHTR6PSEN1PSEN2APH1B
SCHEMBL5434539 0.70 AGTR1 (0.51) ACLYHTR6AGTR1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012059568-A1 NOVEL WATER-SOLUBLE INDOLOBENZAZEPINE MOLECULES DEMONSTRATING ANTIMITOTIC, ANTIVASCULAR, AND ANTITUMOR ACTIVITIES IN VIVO CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-05-10 WO disclosed